Krull Scott M, Moreno Jacqueline, Li Meng, Bilgili Ecevit, Davé Rajesh N
Department of Chemical, Biological, and Pharmaceutical Engineering, New Jersey Institute of Technology, Newark, NJ, United States.
Department of Chemical, Biological, and Pharmaceutical Engineering, New Jersey Institute of Technology, Newark, NJ, United States.
Int J Pharm. 2017 May 15;523(1):33-41. doi: 10.1016/j.ijpharm.2017.03.023. Epub 2017 Mar 16.
Polymer strip films have emerged as a robust platform for poorly water-soluble drug delivery. However, the common conception is that films cannot exceed low drug loadings, mainly due to poor drug stability, slow release, and film brittleness. This study explores the ability to achieve high loadings of poorly water-soluble drug nanoparticles in strip films while retaining good mechanical properties and enhanced dissolution rate. Aqueous suspensions containing up to 30wt% griseofulvin nanoparticles were prepared via wet stirred media milling and incorporated into hydroxypropyl methylcellulose (HPMC) films. Griseofulvin loading in films was adjusted to be between 9 and 49wt% in HPMC-E15 films and 30 and 73wt% in HPMC-E4M films by varying the mixing ratio of HPMC solution-to-griseofulvin suspension. All films exhibited good content uniformity and nanoparticle redispersibility up to 50wt% griseofulvin, while E4M films above 50wt% griseofulvin had slightly worse content uniformity and poor nanoparticle redispersibility. Increasing drug loading in films generally required more time to achieve 100% release during dissolution, although polymer-drug clusters dispersed from E4M films above 50wt% griseofulvin, resulting in similar dissolution profiles. While all films exhibited good tensile strength, a significant decrease in percent elongation was observed above 40-50wt% GF, resulting in brittle films.
聚合物条带薄膜已成为一种用于难溶性药物递送的强大平台。然而,普遍的观念是薄膜的药物载量不能超过低水平,这主要是由于药物稳定性差、释放缓慢以及薄膜脆性。本研究探索了在条带薄膜中实现高载量难溶性药物纳米颗粒的能力,同时保持良好的机械性能和提高溶解速率。通过湿式搅拌介质研磨制备了含高达30wt%灰黄霉素纳米颗粒的水悬浮液,并将其掺入羟丙基甲基纤维素(HPMC)薄膜中。通过改变HPMC溶液与灰黄霉素悬浮液的混合比例,将HPMC-E15薄膜中灰黄霉素的载量调整为9至49wt%,HPMC-E4M薄膜中为30至73wt%。所有薄膜在灰黄霉素载量高达50wt%时均表现出良好的含量均匀性和纳米颗粒再分散性,而灰黄霉素载量高于50wt%的E4M薄膜的含量均匀性略差且纳米颗粒再分散性不佳。增加薄膜中的药物载量通常在溶解过程中需要更多时间才能达到100%释放,尽管从灰黄霉素载量高于50wt%的E4M薄膜中分散出聚合物-药物聚集体,导致溶解曲线相似。虽然所有薄膜都表现出良好的拉伸强度,但在灰黄霉素载量高于40-50wt%时观察到伸长率百分比显著下降,导致薄膜变脆。